Tyler Carter is a Senior Application Scientist at Yokogawa Fluid Imaging Technologies. He received his PhD in Chemistry from the University of Massachusetts Lowell. Over his career in biopharma R&D, he has characterized various formulated modalities, including antibodies (mAbs, BsAbs, TsAbs), ADCs, Fc-fusions, enzymes, and hormones.